Shocking HIV out of hiding: Where are we with clinical trials of latency reversing agents?

Keyphrases

• Clinical Trials 100%
• Latency-reversing Agents 100%
• Virus 80%
• Histone Deacetylase Inhibitor (HDACi) 40%
• Adverse Events 20%
• Immune Cells 20%
• Antiretroviral Therapy 20%
• Mechanism of Action 20%
• CD4+ T 20%
• Latency 20%
• Effector Function 20%
• Cytolysis 20%
• Immune Escape 20%
• HIV-specific T Cells 20%
• Cell-associated HIV RNA 20%
• Addition Strategy 20%
• Latency Reversal 20%
• Disulfiram 20%
• Intervention Strategies 20%
• Latently Infected Cells 20%
• Immune Modulation 20%
• Specific T Cell Response 20%
• Plasma HIV RNA 20%
• Clinical Administration 20%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• Virus 80%
• Histone 40%
• Ribonucleic Acid 40%
• Blood Plasma 20%
• Immunocompetent Cell 20%
• T Cell 20%
• T-Helper Cell 20%
• Immunomodulation 20%
• Cytolysis 20%
• Immune Escape 20%
• Effector Cell 20%